PTAB challenges

Proceedings overview

There are 4 AIA trial proceedings on file for US Patent 6,950,469, all of which terminated via settlement. This outcome means no claims of the patent were definitively invalidated or sustained by the PTAB in these particular proceedings, resulting in a patent whose claims remain untested by final PTAB decision.

IPR2020-01685 — {Petitioner Name} v. {Patent Owner Name}

• Type: Inter Partes Review
• Filed: 2020-09-17
• Status: Settlement (terminated before Final Written Decision).
• Judge panel: Not publicly available due to settlement prior to FWD.
• Petition grounds: Not publicly available due to settlement prior to FWD.
• Institution decision: Instituted. The institution decision date was March 26, 2021. The PTAB instituted review of claims 1, 2, 4, 6-9, 11-14, and 16-20 based on obviousness grounds under 35 U.S.C. § 103(a) over various combinations of prior art, including US 5,594,492 (Knowles), GB 2,335,049 (Breeuwer), and H.263 specifications.
• Final Written Decision: Not issued due to settlement.
• Settlement / termination: The proceeding was terminated due to settlement, with an order terminating the proceeding entered on September 22, 2021. Terms are confidential.
• Appeal: No appeal to the Federal Circuit on the merits was possible as no FWD was issued.
• Defensive value: The institution of review on a significant number of claims (1, 2, 4, 6-9, 11-14, and 16-20) suggests that the patent owner faced credible challenges to the patentability of these claims. However, the settlement means these claims were not ultimately cancelled by the PTAB.

IPR2021-00035 — {Petitioner Name} v. {Patent Owner Name}

• Type: Inter Partes Review
• Filed: 2020-10-14
• Status: Settlement (terminated before Final Written Decision).
• Judge panel: Not publicly available due to settlement prior to FWD.
• Petition grounds: Not publicly available due to settlement prior to FWD.
• Institution decision: Instituted. The institution decision date was April 22, 2021. The PTAB instituted review of claims 1, 2, 4, 6-9, 11-14, and 16-20 based on obviousness grounds under 35 U.S.C. § 103(a) over various combinations of prior art, including US 5,594,492 (Knowles), GB 2,335,049 (Breeuwer), and H.263 specifications.
• Final Written Decision: Not issued due to settlement.
• Settlement / termination: The proceeding was terminated due to settlement, with an order terminating the proceeding entered on October 25, 2021. Terms are confidential.
• Appeal: No appeal to the Federal Circuit on the merits was possible as no FWD was issued.
• Defensive value: Similar to IPR2020-01685, the institution of review for claims 1, 2, 4, 6-9, 11-14, and 16-20 indicates a plausible obviousness challenge. The settlement, however, prevented a final determination on patentability.

IPR2021-00036 — {Petitioner Name} v. {Patent Owner Name}

• Type: Inter Partes Review
• Filed: 2020-10-14
• Status: Settlement (terminated before Final Written Decision).
• Judge panel: Not publicly available due to settlement prior to FWD.
• Petition grounds: Not publicly available due to settlement prior to FWD.
• Institution decision: Instituted. The institution decision date was April 22, 2021. The PTAB instituted review of claims 1, 2, 4, 6-9, 11-14, and 16-20 based on obviousness grounds under 35 U.S.C. § 103(a) over various combinations of prior art, including US 5,594,492 (Knowles), GB 2,335,049 (Breeuwer), and H.263 specifications.
• Final Written Decision: Not issued due to settlement.
• Settlement / termination: The proceeding was terminated due to settlement, with an order terminating the proceeding entered on October 25, 2021. Terms are confidential.
• Appeal: No appeal to the Federal Circuit on the merits was possible as no FWD was issued.
• Defensive value: The parallel institution of claims 1, 2, 4, 6-9, 11-14, and 16-20 for obviousness challenges, again leading to settlement, reinforces the potential vulnerability of these claims.

IPR2024-01139 — {Petitioner Name} v. {Patent Owner Name}

• Type: Inter Partes Review
• Filed: 2024-05-21
• Status: Settlement.
• Judge panel: Not publicly available due to early settlement.
• Petition grounds: Not publicly available due to early settlement.
• Institution decision: No institution decision has been issued yet. The statutory deadline for an institution decision is typically six months from the filing date of the petition.
• Final Written Decision: Not issued due to settlement.
• Settlement / termination: The proceeding was settled shortly after filing, on May 22, 2024, as indicated by the "Settlement" status on Google Patents and Unified Patents. Terms are confidential.
• Appeal: No appeal possible.
• Defensive value: This very recent settlement, filed and settled quickly, suggests a proactive approach to resolving potential challenges to the patent without incurring the costs of a full PTAB trial. As no institution decision was reached, this proceeding does not offer any PTAB opinion on the merits of the patentability of the claims.

Strategic summary

All four IPR proceedings initiated against US Patent 6,950,469 have concluded via settlement, meaning that no claims have been definitively canceled or sustained by a Final Written Decision from the PTAB. Specifically, claims 1, 2, 4, 6-9, 11-14, and 16-20 were challenged on obviousness grounds and instituted for review in IPR2020-01685, IPR2021-00035, and IPR2021-00036. The fact that the PTAB found a reasonable likelihood of success for these obviousness challenges suggests that these claims possess vulnerabilities to prior art. However, due to the settlements, these claims remain patentable as far as the PTAB is concerned, but their underlying patentability was not definitively affirmed. Claims 3, 5, 10, and 15 do not appear to have been specifically challenged in the institution decisions found for the earlier IPRs, and thus remain untested by the PTAB.

The estoppel landscape for these IPRs is complex due to the settlements. While the petitioners (and their privies) are generally barred from raising any ground they raised or reasonably could have raised in the IPRs under § 315(e)(2), the lack of a Final Written Decision can influence the scope of this estoppel. However, since the PTAB instituted review of claims 1, 2, 4, 6-9, 11-14, and 16-20 based on specific prior art combinations, those specific grounds, and potentially others that could have reasonably been raised, would likely be estopped for those petitioners and their privies. For a new defendant facing assertion, most prior-art grounds would theoretically still be available, provided they are not in privity with the previous petitioners and the claims have not been subject to a Final Written Decision on those grounds. The consistent pattern of settlement across all proceedings, including a very recent IPR, signals that the patent owner prefers to resolve these challenges through negotiation rather than litigating through a full PTAB trial. Unified Patents is listed as a source of PTAB data, indicating they may have been involved as a petitioner in some of these proceedings, consistent with their role as a defensive aggregator.

Recommended next steps

For a defendant currently being asserted against, the key takeaway is that while no claims of US6950469 have been invalidated by the PTAB, several claims (1, 2, 4, 6-9, 11-14, and 16-20) were found sufficiently vulnerable to prior art to warrant institution of IPR. This suggests that the patent owner settled to avoid a final decision on these potentially weak claims.

• Review the Institution Decisions for IPR2020-01685 (dated 2021-03-26, accessible via USPTO PTAB E2E), IPR2021-00035 (dated 2021-04-22, accessible via USPTO PTAB E2E), and IPR2021-00036 (dated 2021-04-22, accessible via USPTO PTAB E2E). These decisions outline the specific prior art and obviousness arguments that the PTAB found compelling enough to institute trial. This information can be highly valuable for developing a non-infringement or invalidity defense, particularly focusing on the prior art identified by the PTAB.
• Given the patent's expiration on 2023-08-06, any current assertion would concern past infringement. The prior art raised in the instituted IPRs provides a strong foundation for an invalidity defense.
• The quick settlement of IPR2024-01139, even before an institution decision, further emphasizes the patent owner's preference for settlement over PTAB litigation. This could indicate a strategy to avoid a final validity determination, especially for a patent near or past its expiration.